Form 8-K - Current report:
SEC Accession No. 0001193125-20-231392
Filing Date
2020-08-26
Accepted
2020-08-26 17:00:31
Documents
14
Period of Report
2020-08-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d31580d8k.htm   iXBRL 8-K 26645
2 EX-99.1 d31580dex991.htm EX-99.1 14860
6 GRAPHIC g31580g0827005646644.jpg GRAPHIC 4937
  Complete submission text file 0001193125-20-231392.txt   180962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200826.xsd EX-101.SCH 3088
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200826_lab.xml EX-101.LAB 18908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200826_pre.xml EX-101.PRE 11875
7 EXTRACTED XBRL INSTANCE DOCUMENT d31580d8k_htm.xml XML 3484
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 201137905
SIC: 2834 Pharmaceutical Preparations